Li Du
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 10%
- Graphene and Nanomaterials Applications
- Nanoplatforms for cancer theranostics
Papers in
-
- Bone Metabolism and Diseases 3
- Co-authors
- Gang Wang (2 shared papers)Fei Li (2 shared papers)Xiangyang Shi (3 shared papers)Jingchao Li (2 shared papers)Shao-Ling Wu (3 shared papers)Xindong Zhao (3 shared papers)Junjie Wang (1 shared paper)Xiaoming Peng (2 shared papers)
- Journals
- Oxidative Medicine and Cellular Longevity (3 papers)Scientific Reports (2 papers)Bio-Medical Materials and Engineering (2 papers)Cartilage (1 paper)Neoplasia (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Li Du
40 papers receiving 884 citations
Peers
Comparison fields: 5 of 113
- Biomaterials 227
- Biomedical Engineering 262
- Molecular Medicine 29
- Health, Toxicology and Mutagenesis 78
- Pharmaceutical Science 34
Countries citing papers authored by Li Du
This map shows the geographic impact of Li Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Du more than expected).
Fields of papers citing papers by Li Du
This network shows the impact of papers produced by Li Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Du. The network helps show where Li Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 104 | |
| 2 | 2016 | 76 | |
| 3 | 2014 | 69 | |
| 4 | 2015 | 64 | |
| 5 | 2016 | 60 | |
| 6 | 2015 | 53 | |
| 7 | 2016 | 50 | |
| 8 | 2021 | 47 | |
| 9 | 2021 | 46 | |
| 10 | 2020 | 45 | |
| 11 | 2017 | 38 | |
| 12 | 2021 | 32 | |
| 13 | 2014 | 24 | |
| 14 | 2010 | 22 | |
| 15 | 2014 | 19 | |
| 16 | 2014 | 16 | |
| 17 | 2022 | 15 | |
| 18 | 2007 | 13 | |
| 19 | 2014 | 13 | |
| 20 | 2023 | 12 |
About Li Du
Li Du is a scholar working on Molecular Biology, Materials Chemistry, Biomaterials, Neurology and Oncology, having authored 41 papers that have together received 894 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Graphene and Nanomaterials Applications (3 papers), Electromagnetic Fields and Biological Effects (3 papers), Bone Metabolism and Diseases (3 papers), Environmental Toxicology and Ecotoxicology (2 papers), Cancer Research and Treatments (2 papers), Vitamin C and Antioxidants Research (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Biomaterials (227 citations), Biomedical Engineering (262 citations), Molecular Medicine (29 citations), Health, Toxicology and Mutagenesis (78 citations) and Pharmaceutical Science (34 citations). Li Du has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Gang Wang, Fei Li, Xiangyang Shi, Jingchao Li, Shao-Ling Wu, Xindong Zhao, Junjie Wang, Xiaoming Peng, Jinmin Zhao and Shaohui Zong. Their work appears in journals such as Oxidative Medicine and Cellular Longevity, Scientific Reports, Bio-Medical Materials and Engineering, Cartilage and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.